Daniel A Pollyea

Daniel A Pollyea

UNVERIFIED PROFILE

Are you Daniel A Pollyea?   Register this Author

Register author
Daniel A Pollyea

Daniel A Pollyea

Publications by authors named "Daniel A Pollyea"

Are you Daniel A Pollyea?   Register this Author

78Publications

2572Reads

14Profile Views

How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia.

Leukemia 2019 Dec 18;33(12):2795-2804. Epub 2019 Oct 18.

University of Colorado School of Medicine, Division of Hematology, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0612-8DOI Listing
December 2019

Therapeutic Advances in First-Line Management of Acute Myeloid Leukemia.

Authors:
Daniel A Pollyea

J Natl Compr Canc Netw 2019 Nov;17(11.5):1441-1443

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.5031DOI Listing
November 2019

Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia.

Am J Hematol 2019 Jul 1;94(7):803-811. Epub 2019 May 1.

University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593671PMC
July 2019

CD123 CAR T cells for the treatment of myelodysplastic syndrome.

Exp Hematol 2019 Jun 25;74:52-63.e3. Epub 2019 May 25.

Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X193031
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2019.05.002DOI Listing
June 2019

Acute myeloid leukemia drug development in the post-venetoclax era.

Authors:
Daniel A Pollyea

Am J Hematol 2019 Jun 9. Epub 2019 Jun 9.

Division of Hematology, University of Colorado Department of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25556DOI Listing
June 2019

Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?

Curr Opin Hematol 2019 Mar;26(2):71-76

Department of Medicine, Division of Hematology, University of Colorado, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000485DOI Listing
March 2019

Next-Generation Sequencing and Eating of the Tree of Knowledge.

Authors:
Daniel A Pollyea

Clin Cancer Res 2018 12 23;24(23):5790-5791. Epub 2018 Jul 23.

Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-1835DOI Listing
December 2018

Which novel agents for acute myeloid leukemia are likely to change practice?

Authors:
Daniel A Pollyea

Best Pract Res Clin Haematol 2018 12 20;31(4):391-395. Epub 2018 Sep 20.

Division of Hematology, University of Colorado School of Medicine, 1665 Aurora Court, Aurora, CO, 80045, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.007DOI Listing
December 2018

New drugs for acute myeloid leukemia inspired by genomics and when to use them.

Authors:
Daniel A Pollyea

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):45-50

Division of Hematology, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245963PMC
November 2018

Targeting the Pathway in Acute Myeloid Leukemia.

Clin Cancer Res 2018 10 16;24(20):4931-4936. Epub 2018 May 16.

Division of Hematology, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-0536DOI Listing
October 2018

Functional genomic landscape of acute myeloid leukaemia.

Nature 2018 10 17;562(7728):526-531. Epub 2018 Oct 17.

Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-018-0623-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280667PMC
October 2018

Monocyte function in patients with myelodysplastic syndrome.

J Leukoc Biol 2018 09 14;104(3):641-647. Epub 2018 Apr 14.

Department of Biomedical Research, National Jewish Health, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/JLB.5AB1017-419RRDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113098PMC
September 2018

Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.

Nat Commun 2018 09 12;9(1):3694. Epub 2018 Sep 12.

Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-05984-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135858PMC
September 2018

Shutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein Inhibition.

Curr Hematol Malig Rep 2018 08;13(4):256-264

Division of Hematology, University of Colorado School of Medicine, 1665 Aurora Court, Mail Stop F754, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0464-8DOI Listing
August 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Midostaurin: A New Oral Agent Targeting FMS-Like Tyrosine Kinase 3-Mutant Acute Myeloid Leukemia.

Pharmacotherapy 2017 12 23;37(12):1586-1599. Epub 2017 Nov 23.

Division of Hematology, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/phar.2039
Publisher Site
http://dx.doi.org/10.1002/phar.2039DOI Listing
December 2017

Therapeutic targeting of acute myeloid leukemia stem cells.

Blood 2017 03 3;129(12):1627-1635. Epub 2017 Feb 3.

Division of Hematology, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-10-696039DOI Listing
March 2017

Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.

Cell Rep 2017 03;18(13):3204-3218

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437102PMC
March 2017

ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.

Proc Natl Acad Sci U S A 2016 10 10;113(43):E6669-E6678. Epub 2016 Oct 10.

Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO 80045; School of Medicine, University of Colorado, Aurora, CO 80045; Integrated Department of Immunology, University of Colorado, Aurora, CO 80045; Cancer Biology Program, University of Colorado, Aurora, CO 80045; Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado, Aurora, CO 80045

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1603876113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086999PMC
October 2016

SomVarIUS: somatic variant identification from unpaired tissue samples.

Bioinformatics 2016 03 20;32(6):808-13. Epub 2015 Nov 20.

Department of Medicine, Department of Pharmacology, Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btv685DOI Listing
March 2016

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Blood 2016 Feb 28;127(8):1017-23. Epub 2015 Dec 28.

Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia; School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; School of Molecular and Biological Sciences, University of Adelaide, Adelaide, SA, Australia; Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-676098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968341PMC
February 2016

Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.

J Natl Compr Canc Netw 2015 Apr;13(4):424-34

From Northwestern University Feinberg School of Medicine, Chicago, Illinois; Stanford Cancer Institute, Stanford University, Stanford, California; Duke Cancer Institute, Duke University, Durham, North Carolina; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; University of California, San Francisco, San Francisco, California; Johns Hopkins University School of Medicine, Baltimore, Maryland; Moores Cancer Center, UC San Diego, San Diego, California; University of Colorado Cancer Center, Aurora, Colorado; Fred Hutchinson Cancer Research Center, Seattle, Washington; Dana Farber Cancer Institute, Boston, Massachusetts; Memorial Sloan Kettering Cancer Center, New York; New York; Moffitt Cancer Center and Research Institute, Tampa, Florida; The Ohio State University, Columbus, Ohio; Fred & Pamela Buffett Cancer Center, Omaha, Nebraska; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Roswell Park Cancer Institute, Buffalo, New York; Washington University-Siteman Cancer Center, St Louis, Missouri; St. Jude Children's Research Hospital, Memphis, Tennessee; University of Alabama at Birmingham, Birmingham, Alabama; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; Yale University School of Medicine; New Haven, Connecticut; University of Utah, Salt Lake City, Utah; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; City of Hope Cancer Center, Los Angeles, California; The University of Texas MD Anderson Cancer Center, Houston, Texas; and Mayo Clinic Cancer Center, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0058DOI Listing
April 2015

The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis.

Adv Exp Med Biol 2015 ;815:349-59

Division of Hematology, University of Colorado, Mail Stop F704, 1665 Aurora Court, Room 4320, Aurora, CO, 80045, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-09614-8_20DOI Listing
March 2015

Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.

Clin Cancer Res 2015 Mar 29;21(6):1360-72. Epub 2014 Dec 29.

Integrated Department of Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Cancer Biology Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Department of Medicine, Section of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2014/12/
Web Search
http://clincancerres.aacrjournals.org/content/21/6/1360.full
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-2146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359967PMC
March 2015

Myelodysplastic syndromes, version 2.2015.

J Natl Compr Canc Netw 2015 Mar;13(3):261-72

From Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; UC San Diego Moores Cancer Center; University of Rochester Medical Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; Duke Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Memorial Sloan Kettering Cancer Center; Moffitt Cancer Center; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; University of Colorado Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696005PMC
http://dx.doi.org/10.6004/jnccn.2015.0038DOI Listing
March 2015

Stopping higher-risk myelodysplastic syndrome in its tracks.

Curr Hematol Malig Rep 2014 Dec;9(4):421-31

Division of Hematology, University of Colorado Cancer Center, Aurora, CO, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0234-1DOI Listing
December 2014

Aldehyde dehydrogenases in acute myeloid leukemia.

Ann N Y Acad Sci 2014 Mar;1310:58-68

Division of Hematology, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nyas.12414DOI Listing
March 2014

Expert insights into the contemporary management of older adults with acute myeloid leukemia.

Cancer Control 2013 Oct;20(4 Suppl):5-16

MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481302004s02DOI Listing
October 2013

Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.

J Biol Chem 2011 Apr 17;286(13):11035-46. Epub 2011 Jan 17.

Department of Medicine, Divisions of Oncology and Hematology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.208470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064158PMC
April 2011

Acute myeloid leukaemia in the elderly: a review.

Br J Haematol 2011 Mar;152(5):524-42

Divisions of Hematology and Oncology, Department of Internal Medicine, University Cancer Center, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://www.researchgate.net/profile/Bruno_Medeiros6/publicat
Web Search
http://doi.wiley.com/10.1111/j.1365-2141.2010.08470.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2010.08470.xDOI Listing
March 2011

Utility of influenza vaccination for oncology patients.

J Clin Oncol 2010 May 12;28(14):2481-90. Epub 2010 Apr 12.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.6908DOI Listing
May 2010

When yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stings.

Am J Hematol 2009 Dec;84(12):843-6

Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.21551
Publisher Site
http://dx.doi.org/10.1002/ajh.21551DOI Listing
December 2009

TNP-470 promotes initial vascular sprouting in xenograft tumors.

Mol Cancer Ther 2004 Mar;3(3):335-43

Division of Pediatric Surgery, College of Physicians and Surgeons of Columbia University, New York, NY, USA.

View Article

Download full-text PDF

Source
March 2004